The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2][33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech.

Emergency uses of COVID-19 vaccines from BioNTech and Pfizer, including Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula), have not been approved or licensed by FDA, but …

Oct 15, 2024 · The Pfizer-BioNTech COVID-19 Vaccine (2024-2025 Formula) is authorized for all doses administered to individuals 6 months through 11 years of age to prevent COVID-19.

Aug 28, 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months …

Learn more about the 2024-2025 Formula of COMIRNATY, a COVID-19 vaccine by Pfizer and BioNTech, including how it works, COVID-19 info, and more.

Aug 12, 2025 · The FDA may not renew the emergency use authorization for Pfizer and BioNTech's COVID-19 vaccine in young kids, a Pfizer spokesperson confirmed.

Aug 18, 2022 · The Pfizer BioNTech vaccine against COVID-19 has very high efficacy against severe disease and moderate efficacy against symptomatic SARS-CoV-2 infection. What is …

1 day ago · Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX) "BioNTech" announced today that Health Canada has authorized the LP.8.1 variant adapted COMIRNATY® COVID-19 …

Jul 14, 2025 · What is the Pfizer-BioNTech COVID-19 vaccine? The Pfizer-BioNTech COVID-19 vaccine 2024-2025 Formula is an mRNA COVID-19 vaccine that may help your child develop …

Manufactured for BioNTech Manufacturing GmbH An der Goldgrube 12 55131 Mainz, Germany Marketing Authorization Holder Manufactured by Pfizer Inc. New York, NY 10001 COVID-19 …